Benefits of Using a Transparent Visor to Replace the Face Mask in Speech Therapy Rehabilitation of Oral-Linguo-Facial Praxies in the Context of COVID-19: a Series of Cases

Covid19 Clinical Trial

— Co-VIS  

Official title:

Benefits of Using a Transparent Visor to Replace the Face Mask in Speech Therapy Rehabilitation of Oral-Linguo-Facial Praxies in the Context of COVID-19: a Series of Cases

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04639427
• Other study ID #: APHP200876
• Secondary ID: IDRCB
• Status: Recruiting
• Start date: February 8, 2021
• Est. completion date: July 2021

Study information

• Verified date: July 2021
• Source: Assistance Publique - Hôpitaux de Paris
• Contact: Julie PAQUEREAU, MD
• Phone: + 33 (0)1 47 10 79 00
• Email: julie.paquereau[@]aphp.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The primary objective of the study is to compare the effectiveness of the use of a transparent covering visor with that of the face mask, with or without the use of video sequences, for speech therapy rehabilitation of oral-linguo-facial praxies in the context of the COVID 19 epidemic.

Description:

Statistic analysis: single case experimental design (SCED) method.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 4
• Est. completion date: July 2021
• Est. primary completion date: July 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Aged >= 18 years;

• Hospitalization for more than 2 weeks prior to enrollment in the adult post intensive care rehabilitation care unit (PICRU) of Raymond Poincaré hospital in Garches;

• With oral-linguo-facial praxis disorders whatever the cause;

• Has been informed and not in opposition to participation of the study.

Exclusion Criteria:

• Patient with fever or any suspect symptom of a SARS-CoV2 infection;

• Planned discharge of hospital in 2 weeks;

• Patient with cognitive, phasic or vigilance disorders preventing to understand the study;

• Under guardianship or curator;

• Patient Under french AME scheme.

Related Conditions & MeSH terms

• Communication Disorders
• Covid19
• Facies
• Oral-Linguo-Facial Praxies

Locations

Country	Name	City	State
France	Unité de Soins de Rééducation Post Réanimation, Service de Médecine Physique et de Réadaptation, Hôpital Raymond Poincaré, APHP	Garches

Sponsors (1)

Lead Sponsor	Collaborator
Assistance Publique - Hôpitaux de Paris

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Oral-Linguo-Facial Motricity Test		throughtout of the study, an average of 2 weeks